Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.28p
   
  • Change Today:
    -0.052p
  • 52 Week High: 9.98
  • 52 Week Low: 0.21
  • Currency: UK Pounds
  • Shares Issued: 581.33m
  • Volume: 18,645,423
  • Market Cap: £1.62m
  • RiskGrade: 479
  • Beta: 0.00

Futura Medical Overview

FUTURA MEDICAL is a research and development pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys® technology.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -536.9% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.3 n/a
Pr/Book 0.8  
Latest F'cast
Revenue -87.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Futura Medical Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (5.87) (1.83)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (6.87) (2.03)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.10 (6.89) (2.21)p n/a n/a n/a n/a 0.0%
31-Dec-24 13.93 1.29 0.43p 73.6 n/a n/a n/a 0.0%
31-Dec-25 1.70 (9.07) (2.78)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Futura Medical Company Announcements

Disclosure Table 03-Sep-2026 07:45 RNS
Retail Offer via the BookBuild Platform 03-Sep-2026 07:05 RNS
Fundraise and launch of FSP and M&A process 03-Sep-2026 07:00 RNS

Futura Medical ShareCast News

Total Voting Rights 31-Dec-2025 ShareCast
Notification of major holdings 30-Dec-2025 ShareCast
Notification of major holdings 23-Dec-2025 ShareCast

Futura Medical Top Newspaper Links

Futura's looking brighter after product approval 28-Nov-2008 The Scotsman
Condom breakthrough 10-Aug-2007 The Scotsman
Shares go all floppy 15-May-2007 Sun

Latest Futura Medical Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 0.28p
Change Today -0.052p
% Change -15.76 %
52 Week High 9.98
52 Week Low 0.21
Volume 18,645,423
Shares Issued 581.33m
Market Cap £1.62m
Beta 0.00
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.66% below the market average41.66% below the market average41.66% below the market average41.66% below the market average41.66% below the market average
41.46% above the sector average41.46% above the sector average41.46% above the sector average41.46% above the sector average41.46% above the sector average
Price Trend
90.65% below the market average90.65% below the market average90.65% below the market average90.65% below the market average90.65% below the market average
95.45% below the sector average95.45% below the sector average95.45% below the sector average95.45% below the sector average95.45% below the sector average
Income Not Available
Growth
25.99% above the market average25.99% above the market average25.99% above the market average25.99% above the market average25.99% above the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average

Futura Medical Dividends

No dividends found

Trades for 03-Sep-2026

Time Volume / Share Price
16:35 7,851 @ 0.28p
16:35 3,561 @ 0.28p
16:35 3,036 @ 0.28p
16:35 5,276 @ 0.28p
16:35 37,040 @ 0.28p

Futura Medical Key Personnel

Finance Director Angela Hildreth
CEO Alex Duggan

Top of Page